title: Single night-time doses of 40 mg famotidine or 800 mg cimetidine in the treatment of duodenal ulcer.
abstract: Famotidine (40 mg) and 800 mg cimetidine as single night-time doses were compared in a randomized, double-blind, multicentre study of acute treatment for duodenal ulceration. Fifteen centres recruited 304 patients into the study. Of these, 274 were included for analysis, with 136 receiving famotidine and 138 receiving cimetidine. After 4 weeks, 75% of the patients who received famotidine and 77% of the patients who received cimetidine were healed. At 6 weeks the cumulative healing rates were 91% with famotidine and 87% with cimetidine. Differences between the groups were not significant at 4 or 6 weeks. No significant difference in healing rates between smokers and non-smokers was found. Day and night pain resolved rapidly in both groups. Both treatments were well-tolerated; adverse events were reported in 17 patients on famotidine and 18 on cimetidine, with headache the most frequent event in both groups. Famotidine is effective and well-tolerated in the short-term treatment of duodenal ulcer.
authors.affiliation: Victoria Hospital, Blackpool, UK.
authors.forename: F I
authors.initials: FI
authors.lastname: Lee
authors.forename: S N
authors.initials: SN
authors.lastname: Booth
authors.forename: K M
authors.initials: KM
authors.lastname: Cochran
authors.forename: J
authors.initials: J
authors.lastname: Crowe
authors.forename: R J
authors.initials: RJ
authors.lastname: Dickinson
authors.forename: N P
authors.initials: NP
authors.lastname: Kennedy
authors.forename: J
authors.initials: J
authors.lastname: Cottrell
authors.forename: S G
authors.initials: SG
authors.lastname: Mann
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use; D002927:Cimetidine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D004338:Drug Combinations; D004381:Duodenal Ulcer / Q000188:drug therapy*; D016099:Endoscopy, Gastrointestinal; D015738:Famotidine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008276:Magnesium Hydroxide / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy; D012907:Smoking
chemical_list: D000863:Antacids; D004338:Drug Combinations; C013591:aluminum hydroxide, magnesium hydroxide, drug combination; D000536:Aluminum Hydroxide; D015738:Famotidine; D002927:Cimetidine; D008276:Magnesium Hydroxide